Prognostic and chemotherapy predictive value of gene-expression phenotypes in primary lung adenocarcinoma.
Ringnér, Markus LU
; Jönsson, Göran B
LU
and Staaf, Johan
LU
(2016)
In Clinical Cancer Research
22(1).
p.218-229
- Abstract
- Purpose Primary lung adenocarcinoma remains a deadly disease. Gene expression phenotypes (GEPs) in adenocarcinoma have potential to provide clinically relevant disease stratification for improved prognosis and treatment prediction, given appropriate clinical and methodological validation. Experimental Design 2395 transcriptional adenocarcinoma profiles were assembled from 17 public cohorts and classified by a nearest centroid GEP classifier into three subtypes: terminal respiratory unit (TRU), proximal-proliferative, and proximal-inflammatory, and additionally scored by five transcriptional metagenes representing different biological processes, including proliferation. Prognostic and chemotherapy predictive associations of the subtypes... (More)
- Purpose Primary lung adenocarcinoma remains a deadly disease. Gene expression phenotypes (GEPs) in adenocarcinoma have potential to provide clinically relevant disease stratification for improved prognosis and treatment prediction, given appropriate clinical and methodological validation. Experimental Design 2395 transcriptional adenocarcinoma profiles were assembled from 17 public cohorts and classified by a nearest centroid GEP classifier into three subtypes: terminal respiratory unit (TRU), proximal-proliferative, and proximal-inflammatory, and additionally scored by five transcriptional metagenes representing different biological processes, including proliferation. Prognostic and chemotherapy predictive associations of the subtypes were analyzed by univariate and multivariate analysis using overall survival or distant metastasis-free survival as endpoints. Results Overall, GEPs were associated with patient outcome in both univariate and multivariate analyses, although not in all individual cohorts. The prognostically relevant division was between TRU and non-TRU classified cases, with expression of proliferation-associated genes as a key prognostic component. In contrast, GEP classification was not predictive of adjuvant chemotherapy response. GEP classification showed stability to random perturbations of genes or samples and alterations to classification procedures (typically <10% of cases per cohort switching subtype). High classification variability (>20% of cases switching subtype) was observed when removing larger or entire fractions of a single subtype, due to gene-centering shifts not addressable by the classifier. Conclusions In a large-scale evaluation we show that GEPs add prognostic value to standard clinicopathological variables in lung adenocarcinoma. Subject to classifier refinement and confirmation in prospective cohorts, GEPs have potential to impact the prognostication of adenocarcinoma patients through a molecularly driven disease stratification. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/7844170
- author
- Ringnér, Markus
LU
; Jönsson, Göran B
LU
and Staaf, Johan
LU
- organization
- publishing date
- 2016
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Clinical Cancer Research
- volume
- 22
- issue
- 1
- pages
- 218 - 229
- publisher
- American Association for Cancer Research
- external identifiers
-
- pmid:26265693
- wos:000367550300025
- scopus:84954530331
- pmid:26265693
- ISSN
- 1078-0432
- DOI
- 10.1158/1078-0432.CCR-15-0529
- language
- English
- LU publication?
- yes
- id
- c243bb1f-350a-4071-a1e5-7a2b7cc503fb (old id 7844170)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/26265693?dopt=Abstract
- date added to LUP
- 2016-04-01 10:51:07
- date last changed
- 2023-04-03 19:21:21
@article{c243bb1f-350a-4071-a1e5-7a2b7cc503fb,
abstract = {{Purpose Primary lung adenocarcinoma remains a deadly disease. Gene expression phenotypes (GEPs) in adenocarcinoma have potential to provide clinically relevant disease stratification for improved prognosis and treatment prediction, given appropriate clinical and methodological validation. Experimental Design 2395 transcriptional adenocarcinoma profiles were assembled from 17 public cohorts and classified by a nearest centroid GEP classifier into three subtypes: terminal respiratory unit (TRU), proximal-proliferative, and proximal-inflammatory, and additionally scored by five transcriptional metagenes representing different biological processes, including proliferation. Prognostic and chemotherapy predictive associations of the subtypes were analyzed by univariate and multivariate analysis using overall survival or distant metastasis-free survival as endpoints. Results Overall, GEPs were associated with patient outcome in both univariate and multivariate analyses, although not in all individual cohorts. The prognostically relevant division was between TRU and non-TRU classified cases, with expression of proliferation-associated genes as a key prognostic component. In contrast, GEP classification was not predictive of adjuvant chemotherapy response. GEP classification showed stability to random perturbations of genes or samples and alterations to classification procedures (typically <10% of cases per cohort switching subtype). High classification variability (>20% of cases switching subtype) was observed when removing larger or entire fractions of a single subtype, due to gene-centering shifts not addressable by the classifier. Conclusions In a large-scale evaluation we show that GEPs add prognostic value to standard clinicopathological variables in lung adenocarcinoma. Subject to classifier refinement and confirmation in prospective cohorts, GEPs have potential to impact the prognostication of adenocarcinoma patients through a molecularly driven disease stratification.}},
author = {{Ringnér, Markus and Jönsson, Göran B and Staaf, Johan}},
issn = {{1078-0432}},
language = {{eng}},
number = {{1}},
pages = {{218--229}},
publisher = {{American Association for Cancer Research}},
series = {{Clinical Cancer Research}},
title = {{Prognostic and chemotherapy predictive value of gene-expression phenotypes in primary lung adenocarcinoma.}},
url = {{http://dx.doi.org/10.1158/1078-0432.CCR-15-0529}},
doi = {{10.1158/1078-0432.CCR-15-0529}},
volume = {{22}},
year = {{2016}},
}